347331004: Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Product manufactured as cutaneous dose form (product)\Benzocaine-containing product in cutaneous dose form\Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\...

\Product containing salicylate (product)\Product containing salicylamide (medicinal product)\Product containing benzocaine and salicylamide (medicinal product)\...

\Product containing only benzocaine and salicylamide (medicinal product)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)

\Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)

\Product containing benzocaine (medicinal product)\Benzocaine-containing product in cutaneous dose form\Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Product containing benzocaine (medicinal product)\Product containing benzocaine and salicylamide (medicinal product)\Product containing only benzocaine and salicylamide (medicinal product)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)
\Product containing benzocaine (medicinal product)\Product containing benzocaine and salicylamide (medicinal product)\Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form)\Benzocaine and salicylamide only product in cutaneous dose form\Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3692758017 Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692760015 Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4565171000052111 bensokain 20 milligram/gram och salicylamid 50 milligram/gram, kutan gel sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Product containing benzocaine (medicinal product)	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has active ingredient	Benzocaine (substance)	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Product containing benzocaine and salicylamide (medicinal product)	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	kutan och/eller transdermal läkemedelsform	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has active ingredient	Salicylamide	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	Gel	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has manufactured dose form	Cutaneous gel	true	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	bensokain för lokalt bruk	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	räkning av bas i aktiv ingrediens	två	false	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	g	true	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength denominator unit	g	true	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Salicylamide	false	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	har täljarvärde för koncentrationsstyrka	20	false	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance (attribute)	Salicylamide	false	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance (attribute)	Benzocaine (substance)	false	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Benzocaine (substance)	false	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	har täljarvärde för koncentrationsstyrka	50	false	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Is a	Benzocaine and salicylamide only product in cutaneous dose form	true	Inferred relationship	Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance (attribute)	Salicylamide	true	Inferred relationship	Some	1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has basis of strength substance (attribute)	Benzocaine (substance)	true	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Benzocaine (substance)	true	Inferred relationship	Some	2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has precise active ingredient	Salicylamide	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692758017	Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692760015	Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4565171000052111	bensokain 20 milligram/gram och salicylamid 50 milligram/gram, kutan gel	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)